Savencia is a transformer of milk centered on cheese, dairy specialties, and on dairy ingredients. Co.'s operations are divided into two segments: the Cheese Products segment and the Other Dairy Products segment. In the Cheese Products segment, Co. manufactures and distributes cheeses and cheese specialties. In the Other Dairy Products segment, Co. manufactures and distributes modern butters and long-life creams both for final consumers and professional users, manufactures technical butters and specialized dairy proteins for industrial markets, and manufactures aseptically packaged products.
  • TickerSAVE
  • ISINFR0000120107
  • ExchangeEuronext Paris
  • SectorFood Producers
  • CountryFrance

Analysts

Benoit Valleaux ...
  • Charles Lepetitpas
  • Fatma Agnès Hamdani
  • Jean-François Granjon
  • Nicolas David
  • Roland Pfaender,MBA,CFA,CCRA

ODDO BHF Small & MIDCAP MORNING NEWS - 09/09/2019

...

Fatma Agnès Hamdani

Savencia SA : Continuing improvement in profitability

>Very dynamic Q2 for cheese products - Organic growth came to 4.7% in H1, reflecting strong momentum in the two businesses in Q2, with  increases in sales of 5.4% for cheese products and +8.9% for other dairy products. Momentum was driven by a price effect of 3.2% in H1 with +3.8% in Q2 by our calculations. The estimated volume mix of 1.5% improved sharply in Q2 thanks to cheese products (+2.5% in H1 vs 0.3% in Q1). It increased in certain European countries incl...

Benoit Valleaux ...
  • Charles Lepetitpas
  • Fatma Agnès Hamdani
  • Jean-François Granjon
  • Nicolas David
  • Roland Pfaender,MBA,CFA,CCRA

ODDO BHF Small & MIDCAP MORNING NEWS - 09/09/2019

...

Fatma Agnès Hamdani

Savencia SA : Poursuite de l’amélioration de la rentabilité

>Un T2 très dynamique pour les Produits fromagers - La croissance organique de 4.7% du S1 2019 reflète une forte dynamique des deux activités au T2 qui affichent une hausse des ventes de respectivement 5.4% pour les Produits fromagers et +8.9% pour les autres produits laitiers. Cette dynamique est tirée par un effet prix de 3.2% au S1 dont 3.8% au T2 selon nos calculs. Le mix volume estimé de 1.5% s’est nettement amélioré au T2 grâce aux produits Fromagers (+2.5%...

SAVENCIA is slightly downgraded to Slightly Positive due to an increasingly adverse environment

The independent financial analyst theScreener just slightly lowered the general evaluation of SAVENCIA (FR), active in the Food Products industry. As regards its fundamental valuation, the title confirms its rating of 2 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As of the analysis date September 6, 2019, the closing price was EUR 65.80 and its potential was estimated at EUR 74.01.

Fatma Agnès Hamdani

Savencia SA : Continuing improvement in profitability

>Very dynamic Q2 for cheese products - Organic growth came to 4.7% in H1, reflecting strong momentum in the two businesses in Q2, with  increases in sales of 5.4% for cheese products and +8.9% for other dairy products. Momentum was driven by a price effect of 3.2% in H1 with +3.8% in Q2 by our calculations. The estimated volume mix of 1.5% improved sharply in Q2 thanks to cheese products (+2.5% in H1 vs 0.3% in Q1). It increased in certain European countries incl...

Fatma Agnès Hamdani

Savencia SA : Poursuite de l’amélioration de la rentabilité

>Un T2 très dynamique pour les Produits fromagers - La croissance organique de 4.7% du S1 2019 reflète une forte dynamique des deux activités au T2 qui affichent une hausse des ventes de respectivement 5.4% pour les Produits fromagers et +8.9% pour les autres produits laitiers. Cette dynamique est tirée par un effet prix de 3.2% au S1 dont 3.8% au T2 selon nos calculs. Le mix volume estimé de 1.5% s’est nettement amélioré au T2 grâce aux produits Fromagers (+2.5%...

Fatma Agnès Hamdani

Savencia SA : Résultats S1 2019 meilleurs qu’attendu avec une croissance organique solide de 4.7%. Prudence au S2 au vu du contexte économique

>CA S1 2019 à +4.7% en organique vs +3.6%e et +2.8% au T1. Hausse du ROC de 32% à 95 M€ vs 93 M€e - Savencia a publié hier soir des résultats semestriels solides. Le CA est en hausse de 3.4% à 2 428 M€, soit 1.3% au-dessus de nos attentes de 2 396.5 M€. L’effet changes est négatif de 1.7% en lien avec l’évolution des devises sud-américaines et de l’Europe de l’Est. L’effet périmètre de +0.5% concerne la consolidation de Bake Plus en Corée et de Rogue Cremery aux USA....

Fatma Agnès Hamdani

Savencia SA : Better-than-expected H1 2019 results with solid organic growth of +4.7%. Caution for H2 given the economic context

>H1 2019 sales +4.7% organic vs +3.6% estimated and +2.8% in Q1. Underlying operating profit up 32% to € 95m vs € 93m est. - Yesterday evening, Savencia reported solid interim results. Sales rose 3.4% to € 2,428m, 1.3% higher than our forecast of € 2,396.5m. The forex effect was negative, coming to -1.7%, due to trends in South American and eastern European currencies. The scope effect of +0.5% stemmed from the consolidation of Bake plus in Korea and Rogue Creamery in...

Aurelien Sivignon ...
  • Baptiste Lebacq
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Fehmi Ben Naamane
  • Geoffroy Michalet
  • Hana Maalej
  • Hela Zarrouk
  • Jean-François Granjon
  • Jeremy Garnier
  • Johanna Jourdain
  • Louis Boujard
  • Michael Foundoukidis
  • Nicolas Thorez
  • Philippe Ourpatian
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 04/23/2019

...

A director bought 1,300 shares at 80.500EUR and

A director at Savencia S.A. bought 1,300 shares at 80.500EUR and the significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of...

Benoit Valleaux ...
  • Charles Lepetitpas
  • Fatma Agnès Hamdani
  • Jean-François Granjon
  • Nicolas David
  • Roland Pfaender,MBA,CFA,CCRA

ODDO BHF Small & MIDCAP MORNING NEWS - 09/09/2019

...

Benoit Valleaux ...
  • Charles Lepetitpas
  • Fatma Agnès Hamdani
  • Jean-François Granjon
  • Nicolas David
  • Roland Pfaender,MBA,CFA,CCRA

ODDO BHF Small & MIDCAP MORNING NEWS - 09/09/2019

...

Alfred Glaser ...
  • Antoine Boivin-Champeaux
  • Bruno Cavalier
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Ayachi
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Hela Zarrouk
  • Jeremy Garnier
  • Nicolas David
  • Stephane Houri
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 09/06/2019

We estimate the increase in NAV at end-June at 17% (+€ 643m) to € 4.4bn (€ 176 per share). At 4 September, the increase is slightly lower (+15%). The discount has returned to a historically high level (46% at end-June, 49% at present). In the future, the valuation should continue to increase thanks to a twin source of leverage: the continued rise in NAV and the reduction of the discount. We confirm our Buy recommendation and have edged up our target price to € 134 vs € 132. - Cf. com...

Alfred Glaser ...
  • Antoine Boivin-Champeaux
  • Bruno Cavalier
  • Charles Lepetitpas
  • Christophe Chaput
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Ayachi
  • Fatma Agnès Hamdani
  • Geoffroy Michalet
  • Hela Zarrouk
  • Jeremy Garnier
  • Nicolas David
  • Stephane Houri
  • Yan Derocles

ODDO BHF Small & MIDCAP MORNING NEWS - 06/09/2019

Nous estimons la progression de l’ANR à fin juin à 17% (+643 M€) à 4.4 Md€ (176 € par titre). Au 4 septembre, la progression est légèrement inférieure (+15%). La décote est revenue à un niveau historiquement élevé (46% à fin juin, 49% actuellement). A l’avenir, la valorisation devrait continuer de s’apprécier grâce à un double levier : poursuite de l’augmentation de l’ANR et réduction de la décote. Nous confirmons notre opinion Achat et revoyons en légère hausse notre OC à 134 € vs 13...

Alexandre Iatrides ...
  • Aurelien Sivignon
  • Christophe Chaput
  • Emmanuel Matot
  • Fatma Agnès Hamdani
  • Florent Laroche-Joubert
  • Geoffroy Michalet
  • Hana Maalej
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Johanna Jourdain
  • Matthias Desmarais
  • Nicolas Thorez
  • Stephane Houri

ODDO BHF Small & MIDCAP MORNING NEWS - 04/24/2019

...

SAVENCIA is slightly downgraded to Slightly Positive due to an increasingly adverse environment

The independent financial analyst theScreener just slightly lowered the general evaluation of SAVENCIA (FR), active in the Food Products industry. As regards its fundamental valuation, the title confirms its rating of 2 out of 4 stars while its market behaviour remains unchanged and can be qualified as defensive. However, a marginally less favourable environment forces theScreener to downgrade slightly the title, which now shows an overall rating of Slightly Positive. As of the analysis date September 6, 2019, the closing price was EUR 65.80 and its potential was estimated at EUR 74.01.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

MarketLine Department

Emmi AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Emmi AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Emmi AG since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key Highlights This re...

Jehanne Leroy

Etude de l'AG du 27/04/2017

Tout d'abord, Proxinvest souhaite attirer l'attention des actionnaires sur la décision du Conseil d'administration, en date du 20 avril 2016, de dissocier les fonctions de Président du Conseil d'administra

Matthieu DRIOL

Analyse court terme - SAVENCIA : La tendance de fond est clairement orientée à la baisse.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 62,55 €. La tendance de fond serait remise en cause en cas de franchissement de 78,00 €.

Matthieu DRIOL

Short term view - SAVENCIA : The background trend is clearly bearish.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €62.55. The background trend would be questioned should prices rise above €78.00.

Matthieu DRIOL

Short term view - SAVENCIA : Falling prices.

The background trend is clearly bearish. Prices are falling again, but the movement has become hesitant. The next support is at €64.81. The background trend would be questioned should prices rise above €78.00.

Matthieu DRIOL

Analyse court terme - SAVENCIA : Les prix baissent.

La tendance de fond est clairement orientée à la baisse. Les prix baissent à nouveau, mais le mouvement est devenu hésitant. Le prochain support est à 64,81 €. La tendance de fond serait remise en cause en cas de franchissement de 78,00 €.

Matthieu DRIOL

Medium term view - SAVENCIA : The trend is bearish.

The trend is bearish. The movement goes on. The next target is at €62.55, then €52.24. Passing €90.80 would question the continuation of the fall.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch